How Spinach Extracts Could Treat Dry-Eye Disease

By VirentaNews Staff — May 16, 2026

Can a mammal’s eye harness the power of photosynthesis? That’s the startling question emerging from a 2026 study in Nature that reports mouse retinas were able to perform photosynthesis after being injected with chloroplasts extracted from spinach. While humans are far from growing leaves or generating energy like plants, the experiment challenges long-held assumptions about biological boundaries between kingdoms. The implications are profound: if animal cells can adopt plant machinery to produce energy, could this be a new way to treat degenerative eye diseases like dry-eye syndrome or even retinitis pigmentosa? The study has ignited both excitement and skepticism across the scientific community.

Can Animal Cells Use Plant Chloroplasts?

The answer, surprisingly, is yes—at least in a lab setting. Researchers at the University of Science and Technology of China extracted functional chloroplasts from spinach leaves and encapsulated them in peptide-coated nanoparticles to protect them from the mouse’s immune system. These chloroplasts were then injected into the eyes of live mice with damaged retinas. Using specialized imaging, the team observed that when exposed to light, the chloroplasts generated oxygen and adenosine triphosphate (ATP)—the fundamental energy currency of cells—within retinal tissue. This process mimics photosynthesis, traditionally exclusive to plants, algae, and some bacteria. While the mammalian cells didn’t become fully photosynthetic, they did absorb and utilize the energy produced, suggesting a form of metabolic symbiosis. The study marks the first time plant-derived energy systems have been functionally integrated into a living animal’s nervous tissue.

What Evidence Supports This Breakthrough?

The research team used a combination of fluorescence microscopy, oxygen sensors, and electrophysiological recordings to confirm photosynthetic activity. They reported a 40% increase in ATP levels in treated retinas under bright light, compared to controls. Nature notes that the chloroplasts remained functional for up to 12 hours post-injection, a remarkable lifespan given the hostile environment of mammalian tissue. Dr. Li Wei, lead author, stated, “We didn’t expect the chloroplasts to survive, let alone produce measurable energy. But the retinal neurons showed improved responsiveness to light, suggesting functional benefit.” Independent experts have called the data “rigorous” and “unexpected,” though they emphasize that the effect is localized and temporary. The experiment was replicated across multiple subjects, with consistent results, strengthening the claim that photosynthetic energy transfer occurred in vivo.

Are There Skeptical Views on the Findings?

Despite the compelling data, some scientists urge caution. Dr. Elena Martinez of Harvard Medical School warns that “photosynthesis in a dish is one thing; therapeutic relevance in humans is another.” She points out that the amount of energy generated is minuscule compared to what retinal cells normally require and may not be sufficient to reverse disease. Others question the long-term safety of introducing plant material into human eyes, noting potential immune reactions or oxidative stress from unregulated oxygen production. There’s also debate over whether the observed benefits stem from photosynthesis itself or merely from the anti-inflammatory properties of the delivery nanoparticles. While the study is hailed as innovative, critics argue that calling it “photosynthesis in mammals” may overstate the biological integration achieved. The leap from mice to humans remains vast, both technically and ethically.

What Are the Real-World Implications?

If refined, this technology could transform treatment for conditions where retinal cells starve due to poor blood flow or metabolic dysfunction. Dry-eye disease, which affects over 300 million people globally, involves chronic inflammation and reduced tear production linked to cellular stress. By boosting local ATP levels, photosynthetic therapy might enhance cell survival and function. In more severe cases like retinitis pigmentosa or age-related macular degeneration, where photoreceptors die off, such energy supplementation could slow progression. Early animal trials suggest treated mice showed improved light sensitivity, though not full vision restoration. The approach might one day be combined with gene therapy or retinal implants. However, practical hurdles—like ensuring consistent light exposure to the retina and scaling production of stable chloroplast nanoparticles—remain significant.

What This Means For You

While human trials are years away, this research opens a radical new avenue for treating eye diseases by borrowing nature’s oldest energy system. It suggests that cross-kingdom biology—once considered science fiction—might yield real medical tools. For patients with degenerative vision disorders, it offers a glimmer of hope for therapies that support cellular health from within. Though not a cure, it could complement existing treatments by addressing the metabolic crisis at the heart of many eye conditions.

But fundamental questions remain: Can human retinas safely host plant components long-term? Will the energy boost be enough to make a clinical difference? And could this approach work in other oxygen-starved tissues, like damaged heart or brain cells? As researchers explore these frontiers, the boundary between plant and animal biology grows ever more porous.

Source: Nature